Skip to content
2000
Volume 16, Issue 11
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

The impact of the development of sulfur therapeutics is instrumental to the evolution of the pharmaceutical industry. Sulfur-derived functional groups can be found in a broad range of pharmaceuticals and natural products. For centuries, sulfur continues to maintain its status as the dominating heteroatom integrated into a set of 362 sulfur-containing FDA approved drugs (besides oxygen or nitrogen) through the present. Sulfonamides, thioethers, sulfones and Penicillin are the most common scaffolds in sulfur containing drugs, which are well studied both on synthesis and application during the past decades. In this review, these four moieties in pharmaceuticals and recent advances in the synthesis of the corresponding core scaffolds are presented.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026615666150915111741
2016-05-01
2025-01-24
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026615666150915111741
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test